期刊文献+

雄黄对多发性骨髓瘤细胞株RPMI 8226细胞基因表达谱的作用 被引量:5

Effect of realgar on the gene expression profile of multiple myeloma cell line RPMI 8226
下载PDF
导出
摘要 目的:应用cDNA芯片研究雄黄作用多发性骨髓瘤细胞株RPM I 8226细胞后对其基因表达的影响。方法:应用包含4 096条人类基因的cDNA表达谱芯片,检测雄黄作用于RPM I 8226细胞前及48 h后基因的表达。结果:在mRNA水平上,164条基因显著改变,53条基因上调,111条基因下调。结论:雄黄作用RPM I 8226细胞株后可引起一系列基因改变,许多基因涉及了多发性骨髓瘤的发病机制,其中BTG1,TXNIP及ALK1基因可能与RP-M I 8226细胞的分化和凋亡有密切关系。 Objective To explore the effect of realgar on the gene expression profiles of multiple myeloma cell line RPMI 8226 by applly cDNA microarray. Methods The gene expression of RPMI 8226 cells before and after 48 hours of realgar treatment was determined with a cDNA microarray representing 4 096 human genes. Results At the mRNA level, 164 genes were differentially altered; 53 genes were up-regulated; and 111 genes were down-regulated. Conclusion The realgar treatment to RPMI 8226 cell line may induce a number of gene changes. Many genes may be involved in the pathogenesis of multiple myeloma. BTG1, ALK1, and TXNIP genes may play an important role in the apoptosis and differentiation of RPMI 8226 cells.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2006年第1期24-27,共4页 Journal of Central South University :Medical Science
基金 陕西省科技攻关项目(2001-KG9) 中美国际合作项目
关键词 雄黄 基因芯片 多发性骨髓瘤 RPMI8226细胞 realgar eDNA mieroarray multiple myeloma RPMI 8226 cells
  • 相关文献

参考文献2

二级参考文献42

  • 1王良绪编译.血液肿瘤学:第3版[M].沈阳:辽宁教育出版社,2000.407-540.
  • 2John DV, Guilhern C, Karin T,et al. Identifying intercellular signaling.genes expressed in malignant plasma cells by using complementary DNA arrays[J]. Blood ,2001,98:771-780.
  • 3Yata K, Sadahira Y, Otsuki T, et al. Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1 [ J]. Br J Haematol,2001 , 114:591-599.
  • 4Mazumder S, Gong B, Almasan A, et al. Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells [ J ]. Oncogene, 2000,19 : 2828 -2835.
  • 5Avet-Loiseau H, Gerson F, Magrangeas F, et al. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors[J]. Blood,2001 ,98:3082-3086.
  • 6Avet-Loiseau H,Li JY,Godon C,et al. P53 deletion is not a frequent event in multiple myeloma [ J ]. Br J Haematol, 1999,106 :717-7i9.
  • 7Watts GS, Futscher BW, Isett R, et al. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis sigrraling pathways [ J ]. J Pharmacol Exp Ther,2001,299:434-441.
  • 8John S Jr, Erming T, Jeffrey S, et al. High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH[ J]. Blood ,2000,96 : 1505-1511.
  • 9Elenius K, Paul S, Allison G, et al. Activation of HER4 by hepa-rin-binding EGF-like growth factor stimulates chemotaxis but not proliferation [ J ]. EMBO J, 1997.16 : 1268-1278.
  • 10Costes V, Magen V, Legouffe E, et al. The Mil 5 monoclonal antibody(anti-syndecan-l) is a reliable marker for quantifying plasma cells in paraffin-embeded bone marrow biopsy specimens [ J ].Hum Pathol, 1999,30 : 1405-1411.

共引文献46

同被引文献52

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部